Provider
P4-16 New Drug-Related Prior Authorization Criteria for Myalept
Program effective Date: Jan 08, 2016
Search Results
Displaying 2821 - 2830 of 4204 results
Provider
P33-16 New Drug-Related Prior Authorization Criteria with Quantity Limit for Northera
Program effective Date: Jul 27, 2016
Provider
P11-16 New Drug-Related Prior Authorization Criteria: Idiopathic P ulmonary Fibrosis Prior Authorization with Quantity Limit Criteria: Esbriet ® and Ofev ®
Program effective Date: Feb 08, 2016
Provider
P50-17 Provider Data Accuracy and Identified Lack of Claim Submissions
Program effective Date: Sep 25, 2017
Provider
P30-16 New Prior Authorization Requirement for Lyme Disease: Diagnostic Testing and Intravenous Antibiotic Therapy
Program effective Date: Jul 07, 2016
Provider
P14-16 Addition of Lazanda ® to Existing Drug-Related Prior Authorization with Quantity Limit Program
Program effective Date: Mar 29, 2016
Provider
P49-16 New Drug-Related Prior Authorization Criteria with Quantity Limit for Zavesca
Program effective Date: Oct 27, 2016
Provider
P24-16 Providers will see a change in our Prior Authorization Process for Government Products
Program effective Date: Jun 01, 2016
Provider
P7-16 Addition of Drugs to the Self-Administered Oral Oncology Prior Authorization with Quantity Limit Program
Program effective Date: Jan 27, 2016
Provider
P5-17 Updated: Third Party Payments of Premium and/or Cost-Sharing
Program effective Date: Feb 08, 2017